-
Mashup Score: 0California SB 966 State Legislative Update | AMCP.org - 3 month(s) ago
SB 966, California’s PBM reform bill, could reshape pharmacy benefit manager regulation if signed into law. Governor Newsom’s decision is expected by September 30.
Source: www.amcp.orgCategories: General Medicine News, PayerTweet
-
Mashup Score: 75Arkansas Legislative Council moves to fine Pharmacy Benefit Managers in emergency rule - 4 month(s) ago
Arkansas lawmakers are teaming up against pharmacy benefit managers. Many have been outspoken for months, saying PBMs continue hurting independent pharmacies in the natural state.
Source: www.kark.comCategories: General Medicine News, Hem/OncsTweet-
The Arkansas Legislative Council Executive Subcommittee signed off on an emergency rule on Thursday meant to impact #PBMs immediately. https://t.co/0WRamSLSeQ
-
-
Mashup Score: 33
Popular brand name drugs are becoming increasingly scarce across the five boroughs thanks to abusive practices by middlemen known as pharmacy benefit
Source: www.harlemworldmagazine.comCategories: General Medicine News, Hem/OncsTweet-
Worth the read @BrooksLaSureCMS as your agency @CMSGov does ABSOLUTELY NOTHING to stop low-ball reimbursement in Medicare Part D at the hands of Express Scripts and the top plans/#PBMs. https://t.co/okKvC0TdjM
-
-
Mashup Score: 0Insurers’ big profits stem from care delivery, not core business - 5 month(s) ago
For the likes of UnitedHealth Group and Cigna, the road to ever-larger profits increasingly leads through anything but health insurance.
Source: www.axios.comCategories: General Medicine News, Hem/OncsTweet-
Interesting @axios article by @TreedinDC about insurers making more money off of their #PBMs & related pharmacy offerings & care delivery than the insurance business. https://t.co/AhqHiY8Ycz
-
-
Mashup Score: 79The real reason drug costs are so high in America - 6 month(s) ago
There is a fairly straightforward reason why Americans are paying more for drugs compared to other countries. The problem is the Pharmacy Benefit Manager, commonly known as a PBM.
Source: thehill.comCategories: General Medicine News, Hem/OncsTweet-
"Actually, there is a fairly straightforward reason why Americans are paying more for drugs in general — and Ozempic in particular — compared to other countries. The problem is the Pharmacy Benefit Manager, commonly known as a PBM." #PBMs https://t.co/B8QTKWWyOJ
-
-
Mashup Score: 153FTC Releases Interim Staff Report on Prescription Drug Middlemen - 6 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
RT @FTC: FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1
-
-
Mashup Score: 153FTC Releases Interim Staff Report on Prescription Drug Middlemen - 6 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
RT @FTC: FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1
-
-
Mashup Score: 9FTC Releases Interim Staff Report on Prescription Drug Middlemen - 6 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet-
BREAKING: @FTC releases "inyerim" report on #PBMs. "Thousands of cancer patients depend on these medicines to survive; the PBMs marking up those drugs by up to 4,000 percent the average acquisition cost is enormously significant." https://t.co/CJ2GyvKWne
-
-
Mashup Score: 152FTC Releases Interim Staff Report on Prescription Drug Middlemen - 6 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, CardiologistsTweet-
RT @FTC: FTC releases interim staff report on Prescription Drug Middlemen: https://t.co/YY8sm4TvSs #PBMs /1
-
-
Mashup Score: 9FTC Releases Interim Staff Report on Prescription Drug Middlemen - 6 month(s) ago
The Federal Trade Commission today published an
Source: www.ftc.govCategories: General Medicine News, Hem/OncsTweet-
BREAKING: @FTC releases "inyerim" report on #PBMs. "Thousands of cancer patients depend on these medicines to survive; the PBMs marking up those drugs by up to 4,000 percent the average acquisition cost is enormously significant." https://t.co/CJ2GyvKWne
-
Citing concerns about requiring #PBMs to obtain a license to operate in California, Gov @GavinNewsom has vetoed SB 966 + asks @Cal_HHS to develop transparency package: https://t.co/meObTLzIUD